Jithma P Abeykoon - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jithma P Abeykoon

Showing results (31-40 of 110) with videos related to

Pageof 11

Sort By:

Blood Neoplasia|August 14, 2025

Outcomes of immune checkpoint inhibitor rechallenge in relapsed/refractory Hodgkin lymphomaYoshito Nishimura, Yiqun Han, Nadia Toumeh, et al.

The Oncologist|October 17, 2024

Low magnesium levels and prognosis in newly diagnosed diffuse large B-cell lymphomaJennifer J Gile, Matthew Maurer, Gordon J Ruan, et al.

The American Journal of Surgical Pathology|January 6, 2026

Cyclin D1 Overexpression With Cytoplasmic Localization Distinguishes Erdheim-Chester Disease From Reactive Histiocytic InfiltratesAlma R Oskarsdottir, Aishwarya Ravindran, Matthew J Koster, et al.

European Journal of Haematology|July 2, 2021

MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistanceXiaosheng Wu, Kevin E Nowakowski, Jithma P Abeykoon, et al.

Leukemia & Lymphoma|June 10, 2023

Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2023

Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans CellsAishwarya Ravindran, Surendra Dasari, Gordon J Ruan, et al.

European Journal of Neurology|October 26, 2024

Central nervous system crystal-storing histiocytosis: A case report and literature reviewNabeela Nathoo, Daniel P Larson, Yong Guo, et al.

The American Journal of Surgical Pathology|June 15, 2026

Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is DeceptiveAlyssa M Lee, Neha Seth, Wayne Tam, et al.

Leukemia & Lymphoma|September 25, 2025

PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasmsAishwarya Ravindran, Liuyan Jiang, Gordon J Ruan, et al.

Haematologica|April 24, 2024

Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemiaGordon J Ruan, Xiaosheng Wu, Kimberly A Gwin, et al.

Pageof 11

Search research articles

Showing results (31-40 of 110) with videos related to

Sort By:

Pageof 11

Blood Neoplasia|August 14, 2025

Outcomes of immune checkpoint inhibitor rechallenge in relapsed/refractory Hodgkin lymphomaYoshito Nishimura, Yiqun Han, Nadia Toumeh, et al.

The Oncologist|October 17, 2024

Low magnesium levels and prognosis in newly diagnosed diffuse large B-cell lymphomaJennifer J Gile, Matthew Maurer, Gordon J Ruan, et al.

The American Journal of Surgical Pathology|January 6, 2026

Cyclin D1 Overexpression With Cytoplasmic Localization Distinguishes Erdheim-Chester Disease From Reactive Histiocytic InfiltratesAlma R Oskarsdottir, Aishwarya Ravindran, Matthew J Koster, et al.

European Journal of Haematology|July 2, 2021

MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistanceXiaosheng Wu, Kevin E Nowakowski, Jithma P Abeykoon, et al.

Leukemia & Lymphoma|June 10, 2023

Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2023

European Journal of Neurology|October 26, 2024

Central nervous system crystal-storing histiocytosis: A case report and literature reviewNabeela Nathoo, Daniel P Larson, Yong Guo, et al.

The American Journal of Surgical Pathology|June 15, 2026

Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is DeceptiveAlyssa M Lee, Neha Seth, Wayne Tam, et al.

Leukemia & Lymphoma|September 25, 2025

PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasmsAishwarya Ravindran, Liuyan Jiang, Gordon J Ruan, et al.

Haematologica|April 24, 2024

Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemiaGordon J Ruan, Xiaosheng Wu, Kimberly A Gwin, et al.

Pageof 11